Aerovate Therapeutics, Inc. (NASDAQ:AVTE) to Issue Dividend of $2.40

Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Get Free Report) announced a dividend on Wednesday, April 9th, NASDAQ Dividends reports. Stockholders of record on Friday, April 25th will be given a dividend of 2.40 per share on Monday, April 28th. The ex-dividend date is Tuesday, April 29th.

Aerovate Therapeutics Stock Down 1.5 %

AVTE opened at $2.68 on Friday. Aerovate Therapeutics has a 52 week low of $1.25 and a 52 week high of $25.29. The business's 50 day moving average is $2.53 and its two-hundred day moving average is $2.53. The firm has a market cap of $77.68 million, a price-to-earnings ratio of -0.90 and a beta of 0.95.

Aerovate Therapeutics (NASDAQ:AVTE - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported ($0.09) EPS for the quarter, beating analysts' consensus estimates of ($0.30) by $0.21. Equities analysts expect that Aerovate Therapeutics will post -2.64 EPS for the current fiscal year.

Aerovate Therapeutics Company Profile

Aerovate Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.